Differential selectivity of protein modification by the cyclopentenone prostaglandins PGA1 and 15-deoxy-Delta12,14-PGJ2: role of glutathione.
Cyclopentenone prostaglandins (cyPG) with antiinflammatory and antiproliferative properties have been envisaged as leads for the development of therapeutic agents. Because cyPG effects are mediated in part by the formation of covalent adducts with critical signaling proteins, it is important to assess the specificity of this interaction. By using biotinylated derivatives of 15-deoxy-Delta(12,14)-PGJ(2) (15d-PGJ(2)-B) and PGA(1) (PGA(1)-B) we herein provide novel evidence for the differential selectivity of protein modification by distinct cyPG. The marked quantitative and qualitative differences in the binding of 15d-PGJ(2)-B and PGA(1)-B to cellular proteins were related to a differential reactivity in the presence of glutathione (GSH), both in vitro and in intact cells. Therefore GSH levels may influence not only the intensity but also the specificity of cyPG action.
Gayarre
Javier
J
Departamento de Estructura y Función de Proteínas, Centro de Investigaciones Biológicas, CSIC, Ramiro de Maeztu, Madrid, Spain.
Stamatakis
Konstantinos
K
Renedo
Marta
M
Pérez-Sala
Dolores
D
D000818:Animals; D003517:Cyclopentanes / Q000494:pharmacology; D005978:Glutathione / Q000494:pharmacology / Q000502:physiology*; D051379:Mice; D041681:NIH 3T3 Cells; D015230:Prostaglandin D2 / Q000031:analogs & derivatives* / Q000494:pharmacology; D011454:Prostaglandins A / Q000494:pharmacology*; D011506:Proteins / Q000187:drug effects* / Q000378:metabolism
C097240:15-deoxy-delta(12,14)-prostaglandin J2; D003517:Cyclopentanes; D011454:Prostaglandins A; D011506:Proteins; D005978:Glutathione; C013905:cyclopentenone; D015230:Prostaglandin D2; C100573:prostaglandin A1